10746813

Source:http://linkedlifedata.com/resource/pubmed/id/10746813

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007193, umls-concept:C0030705, umls-concept:C0054836, umls-concept:C0080310, umls-concept:C0599946, umls-concept:C0871261, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C1879547, umls-concept:C2911692
pubmed:issue	1
pubmed:dateCreated	2000-4-24
pubmed:abstractText	We sought to evaluate whether improvement in ejection fraction (EF) with carvedilol therapy is accompanied by improvement in neurohumoral factors.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9442138
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/3-Iodobenzylguanidine, http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Atrial Natriuretic Factor, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Carbazoles, http://linkedlifedata.com/resource/pubmed/chemical/Natriuretic Peptide, Brain, http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine, http://linkedlifedata.com/resource/pubmed/chemical/Propanolamines, http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals, http://linkedlifedata.com/resource/pubmed/chemical/carvedilol
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1071-9164
pubmed:author	pubmed-author:FujimuraMM, pubmed-author:IshidaYY, pubmed-author:KomamuraKK, pubmed-author:MiyatakeKK, pubmed-author:NakataniSS, pubmed-author:YamagishiMM, pubmed-author:YasumuraYY
pubmed:issnType	Print
pubmed:volume	6
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	3-10
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:10746813-3-Iodobenzylguanidine, pubmed-meshheading:10746813-Adrenergic beta-Antagonists, pubmed-meshheading:10746813-Adult, pubmed-meshheading:10746813-Aged, pubmed-meshheading:10746813-Atrial Natriuretic Factor, pubmed-meshheading:10746813-Biological Markers, pubmed-meshheading:10746813-Carbazoles, pubmed-meshheading:10746813-Cardiomyopathy, Dilated, pubmed-meshheading:10746813-Female, pubmed-meshheading:10746813-Heart Ventricles, pubmed-meshheading:10746813-Humans, pubmed-meshheading:10746813-Male, pubmed-meshheading:10746813-Middle Aged, pubmed-meshheading:10746813-Natriuretic Peptide, Brain, pubmed-meshheading:10746813-Norepinephrine, pubmed-meshheading:10746813-Propanolamines, pubmed-meshheading:10746813-Radiopharmaceuticals, pubmed-meshheading:10746813-Recovery of Function, pubmed-meshheading:10746813-Retrospective Studies, pubmed-meshheading:10746813-Stroke Volume, pubmed-meshheading:10746813-Tomography, Emission-Computed, Single-Photon, pubmed-meshheading:10746813-Treatment Outcome, pubmed-meshheading:10746813-Ventricular Function, Left
pubmed:year	2000
pubmed:articleTitle	Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy.
pubmed:affiliation	Department of Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
pubmed:publicationType	Journal Article, Comparative Study